RxDoctor Payments DataLook up a doctor →

Cecille Cruz, NP

Adult Health · Chicago, ILNPI 1548894298

Payments from drug & device makers

$15,171in general payments, 2019–2025

Across 565 payments — averaging $26.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • AstraZeneca$2K
  • Lilly USA, LLC$980
  • Amgen$794
  • AbbVie$727
  • Genentech USA, Inc.$480
  • plus $9K from 54 others

What the payments were for

  • Food & beverage$13,91792%
  • Education$1,2548%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis106$1,691
AstraZeneca(2 entities)33$1,581
Lilly USA, LLC25$980
Amgen24$794
AbbVie29$727
Genentech USA, Inc.21$480
Beigene USA, Inc.11$463
Merck20$442
Jazz Pharmaceuticals Inc.13$425
Incyte Corporation16$425
Servier Pharmaceuticals LLC20$414
Bristol Myers Squibb16$413
Gilead(2 entities)17$388
Johnson & Johnson(2 entities)17$343
Pharmacyclics LLC, An Abbvie Company11$322
Seagen Inc.11$309
Pfizer14$294
Regeneron Healthcare Solutions, Inc.9$288
Eisai Inc.13$283
Takeda Pharmaceuticals U.S.A., Inc.9$247
TG Therapeutics, Inc.1$245
Astellas Pharma US Inc4$244
E.r. Squibb & Sons, L.L.C.10$241
Springworks Therapeutics, Inc.4$229
Sobi, Inc6$205
Beone Medicines USA, Inc.3$195
Sanofi4$194
Rigel Pharmaceuticals, Inc.4$187
Daiichi Sankyo Inc.4$176
GSK5$151
Karyopharm Therapeutics Inc.6$142
Taiho Oncology, Inc.7$111
Geron Corporation4$108
Pharmacosmos Therapeutics Inc.4$98
Bayer4$91
EMD Serono, Inc.4$87
Amneal Pharmaceuticals LLC4$85
G1 Therapeutics, Inc.4$77
Morphosys, US Inc.3$67
Kyowa Kirin, Inc.3$66
Puma Biotechnology, Inc.3$64
Deciphera Pharmaceuticals Inc.2$54
Pharmaessentia USA Corporation2$51
Array Biopharma Inc2$51
Mirati Therapeutics, Inc.2$50
Legend Biotech USA Inc.2$47
Azurity Pharmaceuticals, Inc.2$46
Secura Bio, Inc.2$45
Agios Pharmaceuticals, Inc.2$42
AMAG Pharmaceuticals, Inc.3$40
GE HealthCare2$36
Syndax Pharmaceuticals, Inc.1$33
Dova Pharmaceuticals2$28
Caris MPI, Inc.1$27
Stemline Therapeutics Inc.1$25
CTI Biopharma Corp.1$24
Accord Healthcare, Inc.1$23
Dendreon Pharmaceuticals LLC1$21
Organon1$20
Iovance Biotherapeutics, Inc.2$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,171 in reported general payments places this provider in the 95th percentile of 553 adult health providers in Illinois.

See all adult health providers in Illinois

Medicare billing

Part B allowed, 2024
$1,475
Medicare patients
15
Services billed
17

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban11$5,898
Fentanyl15$2,647
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen42$1,151
Alprazolam19$71

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$294$5,89811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 553 adult health providers in Illinois.

Other adult health in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →